PUPILS at a school in Corfe Mullen have been inspired by sustainable fashion experiments in a mobile lab. Students at Lockyer’s Middle School, part of Initio Learning Trust, have taken part in three ...

Merck KGaA is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 13% over the past three months. However, stock prices are usually driven by a company ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its third-quarter 2024 sales and earnings conference call with institutional ...

In mid-September 2024, a photo allegedly showing actor Keanu Reeves holding a pro-Trump T-shirt spread on social media. The item of clothing displayed variations of the slogan "NEVER STOP FIGHTING ...

Remo Dsouza’s entire life was turned upside down in 2020, when he was diagnosed with a 100 percent heart blockage. The heart attack came as a bigger shock to him because he says he was always ...

On Sunday, Kylie Jenner shared pictures of a new look from her fashion brand Khy and their collaboration with Atlein Paris. The stunning outfit was all white and composed of two pieces. On top was ...

Merck's Keytruda could face competition from a newer medicine. The company's crown jewel will also lose patent exclusivity in a few years. Merck should have the means to get around these headwinds ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

The agreement grants Merck the option to license Evaxion’s preclinical vaccine candidates EVX-B2 and EVX-B3. Evaxion also granted Merck an option to license preclinical vaccine candidates EVX-B2 ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...